Advertisement
Resonance Health Limited

Resonance Health Limited (RHT.AX) Stock Forecast 2027, 2031 & 7-Year Price Prediction

Get the latest Resonance Health Limited (RHT.AX) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

RHT.AXASX
HealthcareMedical - Healthcare Information Services
$0.04
$0.00(0.00%)
Australian Market opens in 16h 34m
Advertisement

Resonance Health Limited (RHT.AX)

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$0.05
Change↑ $0.005 (11.11%)

Quarterly Forecast

Predicted Price$0.05
Change↑ $0.005 (11.11%)

Yearly Forecast

Predicted Price$0.04
Change↓ $-0.00 (-9.55%)

3 Years Forecast

Predicted Price$0.03
Change↓ $-0.02 (-40.99%)

5 Years Forecast

Predicted Price$0.01
Change↓ $-0.03 (-74.75%)

7 Years Forecast

Predicted Price$0.00
Change↓ $-0.04 (-100.00%)

Resonance Health Limited Stock Forecast Summary

Resonance Health Limited (RHT.AX) stock is currently priced at $0.04. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $0.05.

In the long term, RHT.AX shows a bearish trend. The 2027 forecast points to $0.04 (-9.55% change), while the 2031 forecast suggests $0.01 (-74.75% change). Looking 7 years ahead, projections estimate the stock could trade near $0.00, a -100.00% change from today’s price.

Overall Sentiment

Neutral

Short-Term Outlook

Bullish

Long-Term Outlook

Bearish

This mix indicates that Resonance Health Limited stock is expected to trade sideways over the coming years.

Investment Calculator

Estimate your potential returns on RHT.AX using our advanced Investment Calculator with AI-driven price forecasts. Enter your investment amount and select a target date to view expected results, including estimated profit, loss, and ROI performance.

Based on your investment of $1,000.00 in Resonance Health Limited and holding until July 1st, 2027, you could face a potential $95.49 loss, reflecting a -9.5% ROI over the next 365 days. These projections help you better understand short-term market movements.

$

$Shares Bought

22,222.2222

@ $0.05/share

~Forecast Price

$0.04

1-year AI forecast

$Est. Portfolio Value

$904.51

$95.49 loss

%ROI

-9.5%

return on investment

Resonance Health Limited yearly Price Forecast Chart

Explore the yearly forecast chart for RHT.AX, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Resonance Health Limited over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for RHT.AXForecasting details for RHT.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Resonance Health Limited Stock Forecast 2026

The forecast for Resonance Health Limited (RHT.AX) in 2026 suggests a price of $0.04, representing a -9.55% move from today’s price.

Average Target: $0.04

Market Outlook: bearish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

Resonance Health Limited Stock Forecast 2030

By 2030, Meyka AI projects RHT.AX could trade near $0.01, showing a potential -74.75% compared to current levels.

Average Target: $0.01

Market Outlook: bearish.

What could influence the 2030 forecast:
  • Technological innovation and product cycles.
  • Expansion into global markets.
  • Long-term investor sentiment toward Resonance Health Limited.

Frequently Asked Questions